ucsf banner
Helen Diller Family Compr Cancer Ctr
DAVID O. MORGAN, PHD

Vice Chair and Professor, Physiology; Professor, Physiology, Biochemistry, Biophysics, UCSF
Member, UCSF Biomedical Sciences Graduate Program (BMS) and Herbert Boyer Program in Biological Sciences (PIBS)

CONTACT

dmorgan@cgl.ucsf.edu
(415) 476-6695 (voice)
(415) 476-5233 (fax)

Box 2200, UCSF; San Francisco, CA 94143-2200

additional websites:

Morgan Lab Website

EDUCATION

University of Calgary, Canada, B.Sc. (Hon.), 1980, Animal Biology
University of California San Francisco, Ph.D., 1986, Endocrinology
University of California San Francisco, Post-Doc, 1986-1989, Biochemistry

PROFESSIONAL EXPERIENCE

9/81-8/86

Ph.D. student in Endocrinology, Department of Physiology, UCSF, with Richard A. Roth

9/86-7/87

Postdoctoral fellow with William J. Rutter, Department of Biochemistry & Biophysics, UCSF

7/87-9/89

Postdoctoral fellow with Harold E. Varmus, Department of Microbiology & Immunology, UCSF

10/89-6/95

Assistant Professor, Department of Physiology, UCSF. Joint appointment in Department of Biochemistry and Biophysics as of July, 1991

7/95-7/97

Associate Professor, Departments of Physiology and Biochemistry & Biophysics, UCSF

7/97-present

Professor, Departments of Physiology and Biochemistry & Biophysics, UCSF

7/98-present

Vice-chair, Dept. of Physiology, UCSF.

HONORS & AWARDS

1987-1989

Helen Hay Whitney Foundation Postdoctoral Fellowship

1990-1993

Searle Scholar Award

1990-1992

March of Dimes Basil O'Connor Starter Scholar Award

1991-1996

Rita Allen Foundation Scholar Award

SELECTED PUBLICATIONS

De Bondt, H.L., Rosenblatt, J., Jancarik, J., Jones, H.D., Morgan, D.O., and Kim, S.-H. (1993) Crystal structure of cyclin-dependent kinase 2. Nature 363, 595-602.

Gu, Y., Turck, C.W., and Morgan, D.O. (1993) Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710.

Fisher, R.P., and Morgan, D.O. (1994) A novel cyclin associates with MO15/CDK7 to form the CDK activating kinase. Cell 78, 713-724.

Shiekhattar, R., Mermelstein, F., Fisher, R.P., Drapkin, R., Dynlacht, B., Wessling, H.C., Morgan, D.O., and Reinberg, D. (1995) Cdk-activating kinase (CAK) complex is a component of human transcription factor IIH. Nature 374, 283-287.

Fisher, R.P., Jin, P., Chamberlin, H.M., and Morgan, D.O. (1995) Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83, 47-57.

Espinoza, F.H., Farrell, A., Erdjument-Bromage, H., Tempst, P., and Morgan, D.O. (1996) A major cyclin-dependent-kinase-activating kinase (CAK) in budding yeast unrelated to vertebrate CAK. Science 273, 1714-1717.

Kim, K.-K., Chamberlin, H.M., Morgan, D.O., and Kim, S.-H. (1996) Three-dimensional structure of human cyclin H, a positive regulator of the CDK-activating kinase. Nature Structural Biology 3, 849-855.

Jin, P., Hardy, S., and Morgan, D.O. (1998) Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141, 875-885.

Jaspersen, S.L., Charles, J.F., Tinker-Kulberg, R.L., and Morgan, D.O. (1998) A late mitotic regulatory network controlling cyclin destruction in Saccharomyces cerevisiae. Mol. Biol. Cell 9, 2803-2817.

Jaspersen, S.L., Charles, J.F., and Morgan, D.O. (1999) Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14. Curr. Biol. 9, 227-236.

Takizawa, C.G., Weis, K., and Morgan, D.O. (1999) Ran-independent nuclear import of cyclin B1-Cdc2 by importin-ƒÀ. Proc. Natl. Acad. Sci. USA 96, 7938-7943.

Tinker-Kulberg, R., and Morgan, D.O. (1999) Pds1 and Esp1 control both anaphase and mitotic exit in normal cells and following DNA damage. Genes Dev. 13, 1936-1949.

Jaspersen, S.L., and Morgan, D.O. (2000) Cdc14 activates Cdc15 to promote mitotic exit in budding yeast. Curr. Biol. 10, 615-618.

Bishop, A.C., Ubersax, J.A., Petsch, D.T., Matheos, D., Gray, N.S., Blethrow, J., Shimizu, E., Tsien, J.Z., Schultz, P.G., Rose, M.D., Wood, J.L., Morgan, D.O., and Shokat, K.M. (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407, 395-401.

Garrett, S., Barton, W.A., Knights, R., Jin, P., Morgan, D.O., and Fisher, R.P. (2001) Reciprocal activation by CDK2 and CDK7 is directed by substrate specificity determinants outside the T-loop. Mol. Cell Biol. 21, 88-99.

Kraybill, B.C., Elkin, L.L., Blethrow, J.D., Morgan, D.O., and Shokat, K.M. (2002) Inhibitor scaffolds as new allele-specific kinase substrates. J. Amer. Chem. Soc. 124, 12118-12128.

Carroll, C.W., and Morgan, D.O. (2002) The Doc1 subunit is a processivity factor for the anaphase-promoting complex. Nat. Cell Biol. 4, 880-887.

Ubersax, J.A., Woodbury, E.L., Quang, P.N., Paraz, M., Blethrow, J.D., Shah, K., Shokat, K.M., and Morgan, D.O. (2003) Targets of the cyclin-dependent kinase Cdk1. Nature, 425, 859-864.

Carroll, C.W., Enquist-Newman, M., and Morgan, D.O. (2005) The APC subunit Doc1 promotes recognition of the substrate destruction box. Curr. Biol. 15, 11-18.

Loog, M., and Morgan, D.O. (2005) Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates. Nature 434, 104-108. (Commentary: Nature 434, 34-35; and Nat. Rev. Mol. Cell Biol. 6, 280)

Carroll, C.W., and Morgan, D.O. (2005) Enzymology of the Anaphase-Promoting Complex. Meth. Enzymol. 398, 219-230.

Thornton, B.R., Ng, T.M., Matyskiela, M.E., Carroll, C.W., Morgan, D.O., and Toczyski, D.P. (2006) An architectural map of the anaphase-promoting complex. Genes Dev. 20, 449-460.

Book:

Morgan, D.O. (2007) The Cell Cycle: Principles of Control. London: New Science Press.

12/11/06

This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.